Bone Therapy May Not Always Need Monitoring
June 24, 2009 - 12:09pm
390 reads
0 comments
The results support the case against routine monitoring during the early years of treatment, according to an accompanying editorial by Juliet Compston, professor of bone medicine at the University of Cambridge, in England. She said that when changes in bone mineral density are used to monitor treatment, people may be given inappropriate advice.
"Routine monitoring of bone mineral density during the first few years of antiresorptive treatment cannot be justified because it may mislead patients, lead to inappropriate management decisions and waste scarce health care resources," she concluded.
Add A New Comment
Conditions:
Add A New CommentComments
There are no comments yet. Be the first to get the conversation started.